Abcam Plc
(NASDAQ: ABCM)
|
4:00 PM EDT, 09/22/23 | |||
---|---|---|---|---|
Last: $22.55 | Change: -0.04 | %Change: -0.18% | Volume: 10,464,796 |
Open: | $ 22.60 | Volume: | 10,464,796 | |
---|---|---|---|---|
High: | $ 22.65 | Yield(%) | 0.00 | |
Low: | $ 22.55 | P/E Ratio (ttm): | 1328.82 | |
Dividend ($): | n/a | Market Cap ($): | 4.65B | |
EPS ($) | n/a | Shares Out: | 206.01M |
% Price Change (last 4 weeks): | 0.44 |
---|---|
% Price Change (last 13 weeks): | 11.39 |
% Price Change (last 26 weeks): | 71.27 |
% Price Change (last 52 weeks): | 46.88 |
% Price Change (year to date): | 45.18 |
Return on Equity (%): | -1.19 |
---|---|
Return on Assets (%): | -0.80 |
Return on Invested Capital (%): | 3.59 |
Gross Profit Margin (%): | 67.49 |
---|---|
Net Profit Margin (%): | -2.35 |
Operating Profit Margin (%): | 7.85 |
|
|
50-day Moving Average: | $22.85 |
---|---|
200-day Moving Average: | $18.05 |
Avg. Daily Vol. (last 50 days): | 5,419,621 |
Avg. Daily Vol. (last 200 days): | 2,179,990 |
52-wk high: | $25.32 |
52-wk low: | $12.48 |
Bid: | $22.55 |
Ask: | $22.91 |
Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays, and other kits. The company was founded by David Douglas Cleevely, Anthony Kouzarides, and Jonathan Simon Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.
|
Abcam Plc
Discovery Drive Cambridge Biomedical Campus Cambridge EA CB2 0AX Phone: 44.1223.696000 Fax: 44.1223.215.215 http://www.abcamplc.com |
Earnings (1year) ($): | 0.02 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | 1328.82 |
Book Value ($): | 3.82 |
Cash Flow ($): | 0.24 |
Price/Earnings (x): | 1328.82 |
---|---|
Price/Sales (x): | 8.08 |
Price/Book (x): | 4.08 |
Price/Cash Flow (x): | 111.95 |
Quick Ratio (x): | 0.99 |
---|---|
Current Ratio (x): | 1.33 |
LT Debt/Equity (x): | 13.18 |
Total Debt/Equity (x): | 30.80 |